Аннотация:In the race to put existing drugs to the test for coronavirus disease 2019 (COVID-19), a National Institutes of Health–funded team winnowed down about 12 000 approved and investigational drugs to 13 promising candidates against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
